Stephanie Parker Palmer

Special Counsel
Full contact info

As a pragmatic deal lawyer, I guide my clients through third-party contracts at every stage, and I’m at my best running point on complex strategic licensing and collaboration deals.

Passions

Thrifting

Book club

Ballet

Calligraphy

Experience

Autolus Announces Strategic Collaboration With BioNTech, $350 Million Underwritten Offering

February 8, 2024

Cooley advised Autolus – a clinical-stage biopharmaceutical company developing next-generation programmed T-cell therapies – on its strategic collaboration with BioNTech, an immunotherapy company pioneering novel therapies for cancer and other serious diseases, to advance both companies’ autologous CAR-T programs toward commercialization, as well as a $350 million underwritten offering.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Stephanie Parker Palmer
Special Counsel, Reston
Carly Robinson
Associate, Reston
Joe Sandys
Associate, London
Alexandra Paterson
Associate, London
Christian Plaza
Partner, Reston
Courtney Thorne
Partner, Boston
Brian Leaf
Partner, Reston
William DuVal
Associate, Reston
Trevor Bossi
Associate, Boston
Tyler Day
Associate, Reston
Claire Keast-Butler
Partner, London
Mandy Ching
Associate, London
Natasha Kaye
Partner, London
Megan Browdie
Partner, Washington, DC
Ann Bevitt
Partner, London
John Clark
Partner, London
Kevin King
Partner, Washington, DC
Matthew Pavao
Partner, Boston
Barbara Borden
Partner, San Diego
David Wilson
Partner, London
Christine Graham
Special Counsel, London
Rebecca Ross
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Jacqueline Moore
Special Counsel, London
Jack Jones
Associate, London
Rubin Waranch
Associate, Colorado
Jessica Cande
Associate, Boston
Anna Caro
Associate, London
Jan Lang
Associate, Brussels
Eerik Kukebal
Associate, London
Jordan Verrilli
Associate, New York
Matthew S. Scarano
Associate, San Diego
Margaux Arntson
Associate

Related Practices & Industries

Propella Therapeutics Enters Merger Agreement With Astellas Pharma

November 16, 2023

Cooley advised Propella Therapeutics, a privately held biopharmaceutical company that has leveraged a wholly owned proprietary platform that combines medicinal chemistry with lymphatic targeting to create new oncology drugs, on its merger agreement with Astellas Pharma in which Astellas will acquire Propella through a US subsidiary.

Read more

Related contacts

Aaron Binstock
Partner, Washington, DC
Kenneth Krisko
Partner, Reston
Lindsey O'Crump
Associate, Washington, DC
Danielle Joe
Associate, Washington, DC
David Walsh
Partner, Reston
Xander Lee
Partner, Los Angeles Santa Monica
Megan Browdie
Partner, Washington, DC
Howard Morse
Partner, Washington, DC
Steve Tonsfeldt
Partner, Palo Alto
Christopher Kimball
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Mary Maher Lewis
Special Counsel, Reston
Stacey A. Bradford
Special Counsel, Washington, DC
Heather Harrington
Special Counsel, Boston
Stephanie Parker Palmer
Special Counsel, Reston
Stella Sarma
Special Counsel, Brussels
Sharon Connaughton
Special Counsel, Washington, DC
Richard G.S. Lee
Associate, Washington, DC
Jennifer Don
Associate, Reston
John Forrest
Associate, Boston
Kevin Milgram
Associate, Reston
Carly Mitchell
Partner, Washington, DC
Rick Jantz
Associate, Los Angeles Santa Monica
Virat Gupta
Associate, Washington, DC
Amanda Griggs
Associate, New York
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

Lexeo Therapeutics Announces $100 Million IPO

November 3, 2023

Cooley advised Lexeo Therapeutics, a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined subgroup of Alzheimer’s disease, on its approximately $100 million initial public offering.

Read more

Related contacts

Eric Blanchard
Partner, Boston
Peter Byrne
Partner, New York
Div Gupta
Partner, New York
Matthew Pavao
Partner, Boston
Xander Lee
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
Aaron Pomeroy
Partner, Colorado
Phil Mitchell
Partner, New York
Mark Ballantyne
Partner, Reston
Francis Wheeler
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington, DC
Stephanie Parker Palmer
Special Counsel, Reston
Joseph Lockinger
Special Counsel, Washington, DC
Christophe Beauduin
Special Counsel, New York
Randy Sabett
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Dayne Brown
Associate, New York
Ibe Alozie
Associate, Washington, DC
Christopher Nickas
Associate, New York
DeVon Barnett
Associate, Washington, DC
Carly Robinson
Associate, Reston
Calvin Lee
Associate, New York
Jayne M. Munger
Associate, New York
Megan Drill
Associate, San Diego
Erika Freeman
Associate, New York
Mor Agam
Associate, New York
Wyatt Kernell
Associate, Colorado
Wyatt Kernell
Associate, Colorado
Alexander Fullman
Associate, New York
Jason Minio
Paralegal Specialist, Boston
Andrew Henderson
Patent Agent, Seattle
Andrew Leonard
Associate, Washington, DC

Related Practices & Industries

Immatics Announces Collaboration With Moderna

September 11, 2023

Cooley advised Immatics, a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, on its strategic collaboration with Moderna.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Stephanie Parker Palmer
Special Counsel, Reston
J. Brian Stalter
Special Counsel, New York
Carly Robinson
Associate, Reston
David D. Suh
Associate, Palo Alto
Freddy Yip
Associate, Hong Kong
Sharon Connaughton
Special Counsel, Washington, DC
Rubin Waranch
Associate, Colorado
Alexander Israel
Partner in Charge – Brussels, Brussels
Stella Sarma
Special Counsel, Brussels
Jan Lang
Associate, Brussels
Kimberly Nguyen
Special Counsel, Reston
Liza Hadley
Associate, Boston
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
Rachel Thorn
Partner, New York
Matthew Pavao
Partner, Boston

Related Practices & Industries

Immatics Enters Global Exclusive License Agreement With Bristol Myers Squibb

December 22, 2021

Cooley advised Immatics, a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, on its license, development and commercialization agreement with Bristol Myers Squibb for its TCR bispecific candidate, IMA401. Lawyers Ken Krisko, Carly Robinson, Brian Stalter and Stephanie Palmer led the Cooley team advising Immatics.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Carly Robinson
Associate, Reston
J. Brian Stalter
Special Counsel, New York
Stephanie Parker Palmer
Special Counsel, Reston
Nicollette R. Kirby
Associate, Washington, DC
Alexander Israel
Partner in Charge – Brussels, Brussels
Jan Lang
Associate, Brussels
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
Rachel Thorn
Partner, New York
Patrick Van Eecke
Partner, Brussels
Bartholomäus Regenhardt
Associate, Brussels
Stella Sarma
Special Counsel, Brussels
Christine Graham
Special Counsel, London
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

View more

Admissions and credentials

New York

Virginia